Hamid Ghandehari
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.8MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $3.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 13, 2019 | NIH | STTR Phase II In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma | $1K | THERATARGET, INC. |
| Aug 23, 2018 | NIH | STTR Phase I Recombinant Silk Elastin-like Protein Polymers for the Embolization of Cerebral Aneurysms | $150K | THERATARGET, INC. |
| Aug 9, 2018 | NIH | STTR Phase II In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma | $399K | THERATARGET, INC. |
| Aug 21, 2017 | NIH | STTR Phase II In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma | $694K | THERATARGET, INC. |
| Aug 15, 2017 | NIH | STTR Phase I Recombinant Silk Elastin-like Protein Polymers for the Embolization of Cerebral Aneurysms | $400K | THERATARGET, INC. with UNIVERSITY OF UTAH |
| Aug 9, 2017 | NIH | STTR Phase I Recombinant Silk Elastin-like Protein Polymers for the Embolization of Cerebral Aneurysms | $250K | THERATARGET, INC. |
| Sep 9, 2016 | NIH | STTR Phase II In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma | $400K | THERATARGET, INC. |
| Sep 9, 2016 | NIH | STTR Phase II In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma | $1.5M | THERATARGET, INC. with UNIVERSITY OF UTAH |
Peer ranks
Federal funding#428
Awards as PI#190
Patents#273
Companies
- THERATARGET, INC.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.